pubmed-article:15239614 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15239614 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
pubmed-article:15239614 | lifeskim:mentions | umls-concept:C0376387 | lld:lifeskim |
pubmed-article:15239614 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
pubmed-article:15239614 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
pubmed-article:15239614 | lifeskim:mentions | umls-concept:C0085504 | lld:lifeskim |
pubmed-article:15239614 | lifeskim:mentions | umls-concept:C0011065 | lld:lifeskim |
pubmed-article:15239614 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
pubmed-article:15239614 | lifeskim:mentions | umls-concept:C0205473 | lld:lifeskim |
pubmed-article:15239614 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
pubmed-article:15239614 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
pubmed-article:15239614 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:15239614 | pubmed:dateCreated | 2004-7-8 | lld:pubmed |
pubmed-article:15239614 | pubmed:abstractText | Cardiovascular disease is the main cause of death with a functioning graft in renal transplant recipients. Elevated levels of C-reactive protein (CRP) and evidence of chronic Chlamydia pneumoniae infection have been linked to cardiovascular disease and survival in patients with normal renal function and patients with end-stage renal disease on dialysis. So far, no such data have been available in renal transplant recipients. | lld:pubmed |
pubmed-article:15239614 | pubmed:language | eng | lld:pubmed |
pubmed-article:15239614 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15239614 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15239614 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15239614 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15239614 | pubmed:month | May | lld:pubmed |
pubmed-article:15239614 | pubmed:issn | 0041-1337 | lld:pubmed |
pubmed-article:15239614 | pubmed:author | pubmed-author:NashanBjörnB | lld:pubmed |
pubmed-article:15239614 | pubmed:author | pubmed-author:WoywodtAlexan... | lld:pubmed |
pubmed-article:15239614 | pubmed:author | pubmed-author:BrunkhorstRei... | lld:pubmed |
pubmed-article:15239614 | pubmed:author | pubmed-author:HaubitzMarion... | lld:pubmed |
pubmed-article:15239614 | pubmed:author | pubmed-author:GrohAnnemarie... | lld:pubmed |
pubmed-article:15239614 | pubmed:author | pubmed-author:VotschKatrinK | lld:pubmed |
pubmed-article:15239614 | pubmed:author | pubmed-author:HallerHerrman... | lld:pubmed |
pubmed-article:15239614 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15239614 | pubmed:day | 27 | lld:pubmed |
pubmed-article:15239614 | pubmed:volume | 77 | lld:pubmed |
pubmed-article:15239614 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15239614 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15239614 | pubmed:pagination | 1517-21 | lld:pubmed |
pubmed-article:15239614 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:meshHeading | pubmed-meshheading:15239614... | lld:pubmed |
pubmed-article:15239614 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15239614 | pubmed:articleTitle | Serologic evidence of Chlamydia pneumoniae infection as a long-term predictor of cardiovascular death in renal transplant recipients. | lld:pubmed |
pubmed-article:15239614 | pubmed:affiliation | Department of Nephrology, Hannover Medical School, Carl-Neuberg-Strasse-1, 30625 Hannover, Germany. Haubitz.Marion@MH-Hannover.de | lld:pubmed |
pubmed-article:15239614 | pubmed:publicationType | Journal Article | lld:pubmed |